M&T Bank
TGTX icon

M&T Bank’s TG Therapeutics TGTX Stock Holding History

M&T Bank’s Portfolio TGTX Stock Details TGTX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$1.18M Buy
21,403
+7,218
+51% +$295K ﹤0.01% 836
2026
Q1 		$471K Buy
14,185
+4,180
+42% +$125K ﹤0.01% 1152
2025
Q4 		$299K Buy
+10,005
New +$327K ﹤0.01% 1399

Other funds holding TGTX

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
D.E. Shaw & Co
D.E. Shaw & Co New York $210B AUM 57.28% 1-Year Est. Return
SCM
Soleus Capital Management Greenwich, Connecticut $2.9B AUM 169.69% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
ClearBridge Investments
ClearBridge Investments New York $121B AUM 27.52% 1-Year Est. Return
CAM
Congress Asset Management Boston, Massachusetts $16.3B AUM 42.69% 1-Year Est. Return

M&T Bank's TGTX Position: Q2 2026 in Review

M&T Bank increased its TG Therapeutics (TGTX) stake by 51% in Q2 2026, buying an estimated $295K and bringing the position to 21,403 shares worth $1.18M. The position accounts for ﹤0.01% of the portfolio, ranked #836.

M&T Bank first reported a position in TGTX in Q4 2025 and has held it in 3 quarters since. 430 funds tracked by Wall St. Rank hold TGTX as of Q2 2026.

  • M&T Bank held 21,403 shares of TG Therapeutics worth $1.18M as of Q2 2026.
  • M&T Bank bought 7,218 TG Therapeutics shares in Q2 2026, an estimated $295K.
  • TG Therapeutics made up ﹤0.01% of M&T Bank's portfolio in Q2 2026, its #836 holding.
  • M&T Bank first reported a position in TG Therapeutics in Q4 2025 and has held it in 3 quarters since.
  • 430 funds tracked by Wall St. Rank held TG Therapeutics as of Q2 2026.

Based on M&T Bank's 13F filing for Q2 2026, filed 4 Aug 2026.